Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Blue Wavelength Light-blocking Glasses in ADHD-Insomnia [NA]

View source ↗

Summary

A completed clinical trial evaluated blue wavelength light-blocking glasses for ADHD with insomnia and delayed sleep phase symptoms; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • blue wavelength light-blocking glasses

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Attention Deficit Hyperactivity Disorder, Delayed Sleep Phase Type Circadian Rhythm Sleep Disorder | NA | Status: COMPLETED | Results posted: 2014-09-12